Sildenafil Tablet
Product Images NDC 82804-185

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 82804-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-185-90 (Image 01)

Sildenafil 20 mg tablets label from Proficient Rx LP showing prescription only status and NDC 82804-185-90. The label states each tablet contains 20 mg sildenafil citrate equivalent to 20 mg sildenafil, describes the tablet as white, film-coated, circular, biconvex with 'SC' and '20' debossed on sides, and indicates package count of 90 tablets. Marketed by Ajanta Pharma USA Inc., the label also includes storage instructions and safety warnings.*

FDA Label Image

Figure1 (Sildenafil Fig1)

A forest plot chart depicting drug interaction recommendations. It compares the pharmacokinetic parameters (AUC and Cmax) of various interacting drugs when taken with Sildenafil, showing change relative to Sildenafil alone on a logarithmic scale. Each drug listed includes corresponding dose adjustment recommendations such as no dose adjustment or caution advised.*

FDA Label Image

Figure2 (Sildenafil Fig2)

A forest plot chart showing fold changes with 95% confidence intervals for area under the curve (AUC) and maximal concentration (Cmax) of Sildenafil when coadministered with various drugs. The chart includes drugs like Aspirin, Atorvastatin, Bosentan, Doxazosin, Ethinylestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide, with corresponding dose adjustment recommendations.*

FDA Label Image

Figure3 (Sildenafil Fig3)

A line graph depicting the change from baseline in meters over weeks 4, 8, and 12 of a study. The x-axis is labeled "Week of Study" and the y-axis "Change from Baseline (meters)." The graph includes data for Placebo, Sildenafil 20 mg TID, Sildenafil 40 mg TID, and Sildenafil 80 mg TID, each represented by distinctive markers. The legend identifying each group is placed below the graph.*

FDA Label Image

Figure4 (Sildenafil Fig4)

A forest plot showing placebo-corrected changes in 6-minute walk distance (meters) for Sildenafil 20 mg taken three times daily. The plot compares subgroups by baseline walk distance, etiology of pulmonary arterial hypertension, PH functional class, gender, age, mean PAP, and PVRI, with confidence intervals illustrated for each subgroup.*

FDA Label Image

Figure5 (Sildenafil Fig5)

A line graph showing the percentage of subjects without a clinically worsening event over days from randomization, comparing two groups: one receiving placebo and the other sildenafil. The placebo group shows a gradual decline, while the sildenafil group maintains a higher percentage over time.*

FDA Label Image

Structure (Sildenafil Structure)

Chemical structure of Sildenafil, showing its molecular framework including a sulfonamide group and piperazine ring, consistent with the generic drug Sildenafil tablets from Proficient Rx LP.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.